✦ LIBER ✦

Temozolomide promising for malignant gliomas in the elderly

Book ID: 120859655
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200313960-00046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temozolomide beneficial in malignant gli

Temozolomide beneficial in malignant gliomas

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 246 KB

Temozolomide for malignant gliomas: ques

Temozolomide for malignant gliomas: questions remain

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Radiotherapy for malignant gliomas in th

Radiotherapy for malignant gliomas in the elderly

✍ Michael Brada; Sally Patricia Stenning 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

The use of temozolomide in recurrent mal

The use of temozolomide in recurrent malignant gliomas

✍ A. Gaya; J. Rees; A. Greenstein; J. Stebbing 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Intratumoural doxorubicin promising in m

Intratumoural doxorubicin promising in malignant gliomas

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Temozolomide as an alternative to irradi

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

✍ Michael Glantz; Marc Chamberlain; Qin Liu; N. Scott Litofsky; Lawrence D. Recht 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract ## BACKGROUND The optimal treatment for elderly patients (defined as patients 70 years of age or older) with malignant gliomas (MG) remains controversial. Some physicians advocate withholding therapy following diagnosis based on the observation that elderly patients do not tolerate adj